Kaira, Kyoichi
Yamaguchi, Ou
Kawasaki, Tomonori
Hashimoto, Kousuke
Miura, Yu
Shiono, Ayako
Mouri, Atsuto
Imai, Hisao
Kobayashi, Kunihiko
Yasuda, Masanori
Kagamu, Hiroshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K08118, 20K08118)
Article History
Received: 15 October 2022
Accepted: 12 January 2023
First Online: 20 January 2023
Declarations
:
: This study was approved by the Ethics Committee of the International Medical Center, Saitama Medical University (Approval No. 19-075). The requirement for written informed consent was waived by the ethics committee of Saitama Medical University because of the retrospective nature of the study. This study was performed in line with the principles of the Declaration of Helsinki.
: Not applicable.
: KK has received research grants and a speaker honorarium from Ono Pharmaceutical Company, Boehringer Ingelheim, Chugai Pharmaceutical, Taiho Pharmaceutical, Eli Lilly Japan, and AstraZeneca. AM and OY received a speaker honorarium from Eli Lilly, Taiho Pharmaceutical, Pfizer, Chugai Pharmaceutical, and AstraZeneca. HK has received research grants and a speaker honorarium from Ono Pharmaceutical Company, Bristol-Myers Company, Boehringer Ingelheim, MSD, Daiichi Sankyo Company, Chugai Pharmaceutical, Taiho Pharmaceutical, Merck Biopharma Company, Eli Lilly Japan, and AstraZeneca. HI has received research grants and a speaker honorarium from Ono Pharmaceutical Company, AstraZeneca, and Bristol-Myers Company.